These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
496 related articles for article (PubMed ID: 33807818)
21. A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome? Joudi M; Moradi Binabaj M; Porouhan P; PeyroShabany B; Tabasi M; Fazilat-Panah D; Khajeh M; Mehrabian A; Dehghani M; Welsh JS; Keykhosravi B; Akbari Yazdi A; Ariamanesh M; Ghasemi A; Ferns G; Javadinia SA Front Endocrinol (Lausanne); 2022; 13():798975. PubMed ID: 35299966 [TBL] [Abstract][Full Text] [Related]
22. Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis. Rotshild V; Hirsh-Raccah B; Miskin I; Muszkat M; Matok I Sci Rep; 2021 Nov; 11(1):22777. PubMed ID: 34815503 [TBL] [Abstract][Full Text] [Related]
23. The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland. Rzymski P; Zeyland J; Poniedziałek B; Małecka I; Wysocki J Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33919672 [TBL] [Abstract][Full Text] [Related]
24. Early Effectiveness of Four SARS-CoV-2 Vaccines in Preventing COVID-19 among Adults Aged ≥60 Years in Vojvodina, Serbia. Petrović V; Vuković V; Marković M; Ristić M Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335021 [TBL] [Abstract][Full Text] [Related]
25. IgG Antibodies Generation and Side Effects Caused by Ad5-nCoV Vaccine (CanSino Biologics) and BNT162b2 Vaccine (Pfizer/BioNTech) among Mexican Population. Guzmán-Martínez O; Guardado K; de Guevara EL; Navarro S; Hernández C; Zenteno-Cuevas R; Montero H Vaccines (Basel); 2021 Sep; 9(9):. PubMed ID: 34579236 [TBL] [Abstract][Full Text] [Related]
26. Adverse events of active and placebo groups in SARS-CoV-2 vaccine randomized trials: A systematic review. Amanzio M; Mitsikostas DD; Giovannelli F; Bartoli M; Cipriani GE; Brown WA Lancet Reg Health Eur; 2022 Jan; 12():100253. PubMed ID: 34729549 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of COVID-19 vaccines: a systematic review and network meta-analysis of phase 3 randomized controlled trials. Kumar S; Saikia D; Bankar M; Saurabh MK; Singh H; Varikasuvu SR; Maharshi V Pharmacol Rep; 2022 Dec; 74(6):1228-1237. PubMed ID: 36342658 [TBL] [Abstract][Full Text] [Related]
28. Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses. Bos R; Rutten L; van der Lubbe JEM; Bakkers MJG; Hardenberg G; Wegmann F; Zuijdgeest D; de Wilde AH; Koornneef A; Verwilligen A; van Manen D; Kwaks T; Vogels R; Dalebout TJ; Myeni SK; Kikkert M; Snijder EJ; Li Z; Barouch DH; Vellinga J; Langedijk JPM; Zahn RC; Custers J; Schuitemaker H NPJ Vaccines; 2020; 5():91. PubMed ID: 33083026 [TBL] [Abstract][Full Text] [Related]
29. An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times. García-Montero C; Fraile-Martínez O; Bravo C; Torres-Carranza D; Sanchez-Trujillo L; Gómez-Lahoz AM; Guijarro LG; García-Honduvilla N; Asúnsolo A; Bujan J; Monserrat J; Serrano E; Álvarez-Mon M; De León-Luis JA; Álvarez-Mon MA; Ortega MA Vaccines (Basel); 2021 Apr; 9(5):. PubMed ID: 33925526 [TBL] [Abstract][Full Text] [Related]
30. mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects. Fabricius D; Ludwig C; Scholz J; Rode I; Tsamadou C; Jacobsen EM; Winkelmann M; Grempels A; Lotfi R; Janda A; Körper S; Adler G; Debatin KM; Schrezenmeier H; Jahrsdörfer B Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452043 [TBL] [Abstract][Full Text] [Related]
31. Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants. Ikegame S; Siddiquey MNA; Hung CT; Haas G; Brambilla L; Oguntuyo KY; Kowdle S; Vilardo AE; Edelstein A; Perandones C; Kamil JP; Lee B Res Sq; 2021 Apr; ():. PubMed ID: 33851150 [TBL] [Abstract][Full Text] [Related]
32. Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines. Karbiener M; Farcet MR; Zollner A; Masuda T; Mori M; Moschen AR; Kreil TR NPJ Vaccines; 2022 Feb; 7(1):22. PubMed ID: 35181655 [TBL] [Abstract][Full Text] [Related]